A review of the antiviral activity of Chitosan, including patented applications and its potential use against COVID-19

被引：79

作者：

Jaber, Nisrein ^{[1
]}

Al-Remawi, Mayyas ^{[2
]}

Al-Akayleh, Faisal ^{[2
]}

Al-Muhtaseb, Najah ^{[2
]}

Al-Adham, Ibrahim S. I. ^{[2
]}

Collier, Phillip J. ^{[2
]}

机构：

[1] Al Ahliyya Amman Univ, Fac Pharm, Amman, Jordan

[2] Univ Petra, Fac Pharm & Med Sci, Amman, Jordan

来源：

JOURNAL OF APPLIED MICROBIOLOGY | 2022年 / 132卷 / 01期

关键词：

adjuvant; antimicrobial; antiviral; chitosan; coronavirus; COVID; nanoparticles; vaccine; ALGINATE-COATED CHITOSAN; ANTIMICROBIAL PROPERTIES; MOLECULAR-WEIGHT; INFLUENZA-VIRUS; MARINE POLYSACCHARIDES; INTRANASAL VACCINATION; PROTECTIVE IMMUNITY; DRUG-DELIVERY; DNA VACCINE; NANOPARTICLES;

D O I：

10.1111/jam.15202

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Chitosan is an abundant organic polysaccharide, which can be relatively easily obtained by chemical modification of animal or fungal source materials. Chitosan and its derivatives have been shown to exhibit direct antiviral activity, to be useful vaccine adjuvants and to have potential anti-SARS-CoV-2 activity. This thorough and timely review looks at the recent history of investigations into the role of chitosan and its derivatives as an antiviral agent and proposes a future application in the treatment of endemic SARS-CoV-2.

引用

收藏

页码：41 / 58

页数：18

相关论文

共 50 条

[41] Applications of artificial intelligence in battling against covid-19: A literature review [J].

Tayarani, Mohammad-H N. .

CHAOS SOLITONS & FRACTALS, 2021, 142

[42] Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19 [J].

Thimmulappa, Rajesh K. ;

Mudnakudu-Nagaraju, Kiran Kumar ;

Shivamallu, Chandan ;

Subramaniam, K. J. Thirumalai ;

Radhakrishnan, Arun ;

Bhojraj, Suresh ;

Kuppusamy, Gowthamarajan .

HELIYON, 2021, 7 (02)

[43] Use of Natural Compounds as a Potential Therapeutic Agent Against COVID-19 [J].

Wahab, Shadma ;

Ahmad, Irfan ;

Irfan, Safia ;

Baig, Mohammad Hassan ;

Farouk, Abd-ElAziem ;

Dong, Jae-Jun .

CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (09) :1144-1152

[44] Antiviral treatment in COVID-19: which is the most promising? - a narrative review [J].

Yadav, Ambedkar Kumar ;

Wen, Siwan ;

Xu, Xianghuai ;

Yu, Li .

ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (01) :707-720

[45] Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity [J].

Yip, Ashley Jia Wen ;

Low, Zheng Yao ;

Chow, Vincent T. K. ;

Lal, Sunil K. .

VIRUSES-BASEL, 2022, 14 (06)

[46] Use of Antiviral Agents and other Therapies for COVID-19 [J].

Blaskovich, Mark A. T. ;

Verderosa, Anthony D. .

SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 44 (01) :118-129

[47] Insighting isatin derivatives as potential antiviral agents against NSP3 of COVID-19 [J].

Ilyas, Mubashar ;

Muhammad, Shabbir ;

Iqbal, Javed ;

Amin, Saniyah ;

Al-Sehemi, Abdullah G. ;

Algarni, H. ;

Alarfaji, Saleh S. ;

Alshahrani, Mohammad Y. ;

Ayub, Khurshid .

CHEMICAL PAPERS, 2022, 76 (10) :6271-6285

[48] Spices and herbs: Potential antiviral preventives and immunity boosters during COVID-19 [J].

Singh, Namita Ashish ;

Kumar, Pradeep ;

Jyoti ;

Kumar, Naresh .

PHYTOTHERAPY RESEARCH, 2021, 35 (05) :2745-2757

[49] The potential of ODFs as carriers for drugs/vaccines against COVID-19 [J].

Gupta, Maram Suresh ;

Kumar, Tegginamath Pramod .

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2021, 47 (02) :179-188

[50] Vaccination against COVID-19: A systematic review and meta-analysis of acceptability and its predictors [J].

Wang, Qiang ;

Yang, Liuqing ;

Jin, Hui ;

Lin, Leesa .

PREVENTIVE MEDICINE, 2021, 150

← 1 2 3 4 5 →